Clinical Trial Update: TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating transarterial chemoembolization using drug-eluting beads loaded with doxorubicin. The trial targets unresectable liver metastases from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Doxorubicin (Adriamycin) (doxorubicin)

Snippet

Sponsor: Heidelberg University | Conditions: Stage IV Melanoma Patients With Unresectable Liver Metastases | Phase 1, Phase 2 | Status: UNKNOWN